Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 33% ± 13% |
Insufficient scRNA-seq data for expression of CHMP4C at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 871.79 | 327 / 328 | 98% | 39.61 | 175 / 178 |
thymus | 100% | 820.45 | 650 / 653 | 91% | 35.77 | 549 / 605 |
kidney | 99% | 735.20 | 88 / 89 | 91% | 19.73 | 823 / 901 |
prostate | 90% | 558.82 | 220 / 245 | 99% | 54.05 | 499 / 502 |
stomach | 76% | 673.12 | 274 / 359 | 97% | 51.05 | 276 / 286 |
liver | 96% | 317.90 | 216 / 226 | 77% | 16.81 | 313 / 406 |
lung | 75% | 311.16 | 434 / 578 | 97% | 37.25 | 1125 / 1155 |
breast | 68% | 492.48 | 312 / 459 | 98% | 48.49 | 1094 / 1118 |
bladder | 52% | 367.05 | 11 / 21 | 97% | 48.85 | 487 / 504 |
intestine | 48% | 439.91 | 460 / 966 | 99% | 56.80 | 520 / 527 |
esophagus | 47% | 589.87 | 677 / 1445 | 92% | 27.27 | 168 / 183 |
adrenal gland | 97% | 435.84 | 249 / 258 | 20% | 3.43 | 46 / 230 |
ovary | 4% | 9.12 | 7 / 180 | 97% | 28.95 | 418 / 430 |
ureter | 0% | 0 | 0 / 0 | 100% | 85.95 | 1 / 1 |
spleen | 98% | 431.94 | 236 / 241 | 0% | 0 | 0 / 0 |
uterus | 9% | 32.46 | 16 / 170 | 88% | 32.18 | 402 / 459 |
tonsil | 0% | 0 | 0 / 0 | 93% | 26.27 | 42 / 45 |
blood vessel | 85% | 432.02 | 1136 / 1335 | 0% | 0 | 0 / 0 |
skin | 72% | 1394.05 | 1304 / 1809 | 5% | 0.66 | 23 / 472 |
heart | 38% | 80.40 | 328 / 861 | 0% | 0 | 0 / 0 |
adipose | 26% | 54.12 | 311 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 14% | 40.46 | 126 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.25 | 1 / 29 |
eye | 0% | 0 | 0 / 0 | 1% | 0.41 | 1 / 80 |
brain | 0% | 0.91 | 12 / 2642 | 0% | 0.03 | 2 / 705 |
muscle | 0% | 0.42 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0001778 | Biological process | plasma membrane repair |
GO_0051469 | Biological process | vesicle fusion with vacuole |
GO_0032466 | Biological process | negative regulation of cytokinesis |
GO_0039702 | Biological process | viral budding via host ESCRT complex |
GO_0036258 | Biological process | multivesicular body assembly |
GO_0009838 | Biological process | abscission |
GO_0061763 | Biological process | multivesicular body-lysosome fusion |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_0016236 | Biological process | macroautophagy |
GO_0044878 | Biological process | mitotic cytokinesis checkpoint signaling |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0061952 | Biological process | midbody abscission |
GO_0090148 | Biological process | membrane fission |
GO_0006997 | Biological process | nucleus organization |
GO_0010824 | Biological process | regulation of centrosome duplication |
GO_0032511 | Biological process | late endosome to vacuole transport via multivesicular body sorting pathway |
GO_0046761 | Biological process | viral budding from plasma membrane |
GO_1902774 | Biological process | late endosome to lysosome transport |
GO_0071985 | Biological process | multivesicular body sorting pathway |
GO_0006900 | Biological process | vesicle budding from membrane |
GO_0015031 | Biological process | protein transport |
GO_0006914 | Biological process | autophagy |
GO_0097352 | Biological process | autophagosome maturation |
GO_0090611 | Biological process | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway |
GO_0007080 | Biological process | mitotic metaphase chromosome alignment |
GO_0031468 | Biological process | nuclear membrane reassembly |
GO_0000815 | Cellular component | ESCRT III complex |
GO_0030496 | Cellular component | midbody |
GO_0005643 | Cellular component | nuclear pore |
GO_0005886 | Cellular component | plasma membrane |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0000776 | Cellular component | kinetochore |
GO_0000421 | Cellular component | autophagosome membrane |
GO_0090543 | Cellular component | Flemming body |
GO_0005828 | Cellular component | kinetochore microtubule |
GO_0005829 | Cellular component | cytosol |
GO_0005771 | Cellular component | multivesicular body |
GO_1904930 | Cellular component | amphisome membrane |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CHMP4C |
Protein name | Charged multivesicular body protein 4c (Chromatin-modifying protein 4c) (CHMP4c) (SNF7 homolog associated with Alix 3) (SNF7-3) (hSnf7-3) (Vacuolar protein sorting-associated protein 32-3) (Vps32-3) (hVps32-3) |
Synonyms | SHAX3 |
Description | FUNCTION: Probable core component of the endosomal sorting required for transport complex III (ESCRT-III) which is involved in multivesicular bodies (MVBs) formation and sorting of endosomal cargo proteins into MVBs. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. The MVB pathway appears to require the sequential function of ESCRT-O, -I,-II and -III complexes. ESCRT-III proteins mostly dissociate from the invaginating membrane before the ILV is released. The ESCRT machinery also functions in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and the budding of enveloped viruses (HIV-1 and other lentiviruses). Key component of the cytokinesis checkpoint, a process required to delay abscission to prevent both premature resolution of intercellular chromosome bridges and accumulation of DNA damage: upon phosphorylation by AURKB, together with ZFYVE19/ANCHR, retains abscission-competent VPS4 (VPS4A and/or VPS4B) at the midbody ring until abscission checkpoint signaling is terminated at late cytokinesis. Deactivation of AURKB results in dephosphorylation of CHMP4C followed by its dissociation from ANCHR and VPS4 and subsequent abscission . ESCRT-III proteins are believed to mediate the necessary vesicle extrusion and/or membrane fission activities, possibly in conjunction with the AAA ATPase VPS4. Involved in HIV-1 p6- and p9-dependent virus release. CHMP4A/B/C are required for the exosomal release of SDCBP, CD63 and syndecan . . |
Accessions | ENST00000297265.5 Q96CF2 |